Open house Arzneimittelrabattverträge Roxithromycin, ATC J01FA06
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Roxithromycin, ATC J01FA06
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume; actual uptake may be low or zero.
Open house agreements automatically cease if a regular discount contract for the same active substance is concluded via...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until May 2027
- Supply of Roxithromycin (ATC J01FA06) under non-exclusive discount agreements
- Agreement with AOK Bayern for the period 01.06.2025 to 31.05.2027
Show full summary
Open house model for non-exclusive pharmaceutical discount agreements for Roxithromycin (ATC J01FA06) with AOK Bayern. All eligible pharmaceutical companies can conclude identical, non-negotiable discount agreements. Contract term from 01.06.2025 to 31.05.2027. No estimated value provided. This is not a formal procurement procedure.
Risks
No estimated value or volume; actual uptake may be low or zero.
Open house agreements automatically cease if a regular discount contract for the same active substance is concluded via...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Only pharmaceutical companies may participate
Administrative
- Submit a signed declaration of reliability
- Submit signed contract and appendix 'Festlegung der vertragsgegenständlichen Arzneimittel'
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Roxithromycin, ATC J01FA06
Non-exclusive discount agreements for the active substance Roxithromycin (ATC J01FA06). Contract term 01.06.2025-31.05.2027. Rolling submission; contracts can be concluded at any time until 05.04.2027.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria
this is an open house model where any eligible pharmaceutical company may conclude a contract.
Value note
Show original TED data
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Procurement Details
- Publication date
- 15 Apr 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 248073-2025
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume; actual uptake may be low or zero.
Open house agreements automatically cease if a regular discount contract for the same active substance is concluded via...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications